Asclera is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Merz North America, Inc. The primary component is Polidocanol.
Product ID | 46783-221_1781730d-b81e-4e88-8218-b07b854e03cb |
NDC | 46783-221 |
Product Type | Human Prescription Drug |
Proprietary Name | Asclera |
Generic Name | Polidocanol |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-06-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021201 |
Labeler Name | Merz North America, Inc |
Substance Name | POLIDOCANOL |
Active Ingredient Strength | 0 g/mL |
Pharm Classes | Sclerosing Agent [EPC],Sclerosing Activity [MoA],Vascular Sclerosing Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2010-06-01 |
Marketing End Date | 2022-08-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021201 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-01 |
Ingredient | Strength |
---|---|
POLIDOCANOL | .01 g/mL |
SPL SET ID: | 90550274-6605-44de-8c25-c5591080270f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
46783-121 | Asclera | POLIDOCANOL |
46783-221 | Asclera | POLIDOCANOL |
67850-140 | Asclera | POLIDOCANOL |
67850-141 | Asclera | POLIDOCANOL |
60635-107 | Varithena | polidocanol |
60635-111 | Varithena | polidocanol |
60635-118 | Varithena | polidocanol |
60635-123 | Varithena | polidocanol |
60635-133 | Varithena | polidocanol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ASCLERA 90035122 not registered Live/Pending |
Chemische Fabrik Kreussler & Co. GmbH 2020-07-03 |
ASCLERA 77840002 3842974 Dead/Cancelled |
Chemische Fabrik Kreussler & Co. GmbH 2009-10-02 |